Korro Bio, Inc. Earnings Per Share, Basic and Diluted
Korro Bio, Inc. (KRRO) reported Earnings Per Share, Basic and Diluted of -$0.61 per share for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-09.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-08-09
- Korro Bio, Inc. earnings per share, basic and diluted for the quarter ending 2022-06-30 was -$0.61.
- Korro Bio, Inc. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.67.
- Korro Bio, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.73.
- Korro Bio, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.52.
- Korro Bio, Inc. earnings per share, basic and diluted for fiscal 2021 was -$2.47.
- Korro Bio, Inc. earnings per share, basic and diluted for fiscal 2020 was -$0.82.
- Korro Bio, Inc. earnings per share, basic and diluted for fiscal 2019 was -$2.29.
- Korro Bio, Inc. earnings per share, basic and diluted for fiscal 2018 was -$12.53.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-06-30 | -$0.61 10-Q · filed 2022-08-09 | -$1.28 10-Q · filed 2022-08-09 | ||
| 2022-03-31 | -$0.67 10-Q · filed 2022-05-04 | |||
| 2021-12-31 | -$2.47 10-K · filed 2022-03-15 | |||
| 2021-09-30 | -$0.73 10-Q · filed 2021-11-15 | -$1.84 10-Q · filed 2021-11-15 | ||
| 2021-06-30 | -$0.52 10-Q · filed 2022-08-09 | -$1.11 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | -$0.60 10-Q · filed 2022-05-04 | -$0.90 derived: net income ÷ weighted average shares · filed 2022-05-04 | -$1.07 derived: net income ÷ weighted average shares · filed 2022-05-04 | -$1.27 derived: net income ÷ weighted average shares · filed 2022-05-04 |
| 2020-12-31 | -$0.30 10-K · filed 2021-03-29 | -$0.47 derived: net income ÷ weighted average shares · filed 2022-03-15 | -$0.66 derived: net income ÷ weighted average shares · filed 2022-03-15 | -$0.82 10-K · filed 2022-03-15 |
| 2020-09-30 | -$0.16 10-Q · filed 2021-11-15 | -$0.35 derived: net income ÷ weighted average shares · filed 2021-11-15 | -$0.51 10-Q · filed 2021-11-15 | -$0.71 derived: net income ÷ weighted average shares · filed 2021-11-15 |
| 2020-06-30 | -$0.19 10-Q · filed 2021-08-12 | -$0.35 10-Q · filed 2021-08-12 | -$0.55 derived: net income ÷ weighted average shares · filed 2021-08-12 | -$0.78 derived: net income ÷ weighted average shares · filed 2021-08-12 |
| 2020-03-31 | -$0.16 10-Q · filed 2021-05-13 | -$0.35 derived: net income ÷ weighted average shares · filed 2021-05-13 | -$0.59 derived: net income ÷ weighted average shares · filed 2021-05-13 | -$1.19 derived: net income ÷ weighted average shares · filed 2021-05-13 |
| 2019-12-31 | -$0.19 10-K · filed 2021-03-29 | -$0.46 derived: net income ÷ weighted average shares · filed 2021-03-29 | -$1.28 derived: net income ÷ weighted average shares · filed 2021-03-29 | -$2.29 10-K · filed 2021-03-29 |
| 2019-09-30 | -$0.73 10-K · filed 2021-03-29 | -$4.05 derived: net income ÷ weighted average shares · filed 2021-03-29 | -$7.17 10-Q · filed 2020-11-16 | -$10.30 derived: net income ÷ weighted average shares · filed 2021-03-29 |
| 2019-06-30 | -$3.42 10-K · filed 2021-03-29 | -$6.67 10-Q · filed 2020-08-12 | -$9.90 derived: net income ÷ weighted average shares · filed 2021-03-29 | -$13.16 derived: net income ÷ weighted average shares · filed 2021-03-29 |
| 2019-03-31 | -$3.24 10-K · filed 2021-03-29 | -$6.46 derived: net income ÷ weighted average shares · filed 2021-03-29 | -$9.72 derived: net income ÷ weighted average shares · filed 2021-03-29 | |
| 2018-12-31 | -$3.23 10-K · filed 2020-03-26 | -$6.48 derived: net income ÷ weighted average shares · filed 2020-03-26 | -$12.53 10-K · filed 2020-03-26 | |
| 2018-09-30 | -$3.26 10-K · filed 2020-03-26 | -$9.29 10-Q · filed 2019-11-18 | ||
| 2018-06-30 | -$3.01 10-K · filed 2020-03-26 | |||
| 2018-03-31 | -$3.03 10-K · filed 2020-03-26 | |||
| 2017-12-31 | -$28.79 10-K · filed 2020-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |